Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Obesity (Silver Spring, Md.)|March 6, 2023
Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case-control studyJosé Ignacio Martínez-Montoro, María Ángeles Núñez-Sánchez, María Antonia Martinez-Sanchez, et al.
Nutrients|May 11, 2024
Triglyceride to HDL Cholesterol Ratio for the Identification of MASLD in Obesity: A Liver Biopsy-Based Case-Control StudyJosé Ignacio Martínez-Montoro, María Antonia Martínez-Sánchez, Andrés Balaguer-Román, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 15, 2024
The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomesDaniel Castellano-Castillo, María Ángeles Núñez-Sánchez, Andrés Balaguer-Román, et al.
Diabetes|December 5, 2020
Loss of Furin in β-Cells Induces an mTORC1-ATF4 Anabolic Pathway That Leads to β-Cell DysfunctionBas Brouwers, Ilaria Coppola, Katlijn Vints, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 26, 2023
Plasma short-chain fatty acid changes after bariatric surgery in patients with severe obesityMaría A Martínez-Sánchez, Andrés Balaguer-Román, Virginia E Fernández-Ruiz, et al.
International Journal of Surgery (London, England)|July 8, 2022
Dietary modulation of gut microbiota in patients with colorectal cancer undergoing surgery: A reviewJosé Ignacio Martínez-Montoro, María Antonia Martínez-Sánchez, Andrés Balaguer-Román, et al.
Cellular and Molecular Gastroenterology and Hepatology|November 15, 2025
Intestinal Epithelial Cell-derived Osteopontin Protects Against Metabolic Dysfunction-associated Steatohepatitis by Modulating Bile Acid Composition and the Gut MicrobiomeHui Han, Jeongwoo Park, Rui Zhang, et al.
Journal of Clinical Medicine|June 13, 2025
Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Adult Patients with Crohn's Disease: Protocol for a Prospective, Interventional, Controlled, Randomized Clinical TrialRosario Paloma Cano-Mármol, Virginia Esperanza Fernández-Ruiz, Cristina Martínez-Pascual, et al.
Lipids in Health and Disease|October 15, 2025
ApoJ and apoL1 as novel determinants of MASH: a cross-sectional studyZichun Cai, Souad Najib, María A Núñez-Sánchez, et al.
The Journal of Pathology|July 18, 2024
Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver diseaseMaría Ángeles Núñez-Sánchez, María Antonia Martínez-Sánchez, Marta Sierra-Cruz, et al.
Pageof 11